- Aurora Cannabis (ACB) has closed the sale of its Aurora Polaris facility for gross proceeds of $15 million
- Aurora announced in 2021 that it would close the Alberta property as part of a plan to streamline its operations
- Manufacturing will be relocated to Aurora River in Bradford, Ontario
- Aurora is a Canada-based cannabis company serving the medical and retail markets
- Aurora Cannabis Inc. (ACB) is down 5.01 per cent on the day, trading at C$0.905 per share at 2:15 pm ET
Aurora Cannabis (ACB) has closed the sale of its Aurora Polaris facility for gross proceeds of approximately $15 million.
In May 2022, the company announced plans to close several other facilities — including the Sky facility and two in British Columbia — to cope with pricing pressures that ate into revenues already hampered by the COVID-19 pandemic.
The company said at the time eight per cent of its global workforce would be impacted by the closure.
The location’s medical distribution operations will be relocated to the Aurora Sky facility near Leduc, Alberta, while manufacturing will be relocated to Aurora River in Bradford, Ont.
The Aurora Polaris facility was about 2,787 square metres, with one-third of the space dedicated to warehousing and distribution of cannabis products and the remainder hosting product manufacturing.
The company’s current balance sheet remains in a net cash position, with about $320 million of cash and cash equivalents, including about $63 million of restricted cash.
Aurora also reiterated its expectation of achieving profitability based on adjusted earnings before interest, taxes, depreciation and amortization for the quarter ended Dec. 31, 2022.
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71.
Aurora Cannabis Inc. (ACB) is down 5.01 per cent on the day, trading at C$0.905 per share at 2:15 pm ET.
